KALA BIO, Inc. (0JQ2.L) LSE
3.04
+0.06(+2.01%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.04
+0.06(+2.01%)
Currency In USD
| Market Cap | 4.48M |
| Enterprise Value | -3.08M |
| P/E Ratio | -0.92 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.56 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.73 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.84 |
| Return On Equity | -129.56 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -317,000 |
| EBITDA | -42.09M |
| Net Income | -26.98M |
| Diluted EPS | -3.31 |
| Total Cash | 7.56M |
| Total Cash/Share | 0.93 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.81 |
| Book Value Per Share | 0.86 |
| 52-Week Change | -6.73 |
| 52-Week High | 19.48 |
| 52-Week Low | 2.99 |
| Moving Average 50 Days | 7.08 |
| Moving Average 200 Days | 11.17 |
| Average Volume | 320 |
| Shares Outstanding | 7.02M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
| Last Split Date | January 20, 2023 |